Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Double minute amplification of mutant PDGF receptor α in a mouse glioma model
Hongyan Zou1, Rui Feng2, Yong Huang2
11] Fishberg Department of Neuroscience, Friedman Brain Institute [2] Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Abstract:
In primary brain tumors, oncogenes are frequently amplified and maintained on extrachromosomal DNA as double minutes (DM), but the underlying mechanisms remain poorly understood. We have generated a mouse model of malignant glioma based on knock-in of a mutant PDGF receptor α (PDGFRα) that is expressed in oligodendrocyte precursor cells (OPCs) after activation by a Cre recombinase. In the tumor suppressor INK4/Arf(-/-) background, mutant animals frequently developed brain tumors resembling anaplastic human gliomas (WHO grade III). Besides brain tumors, most animals also developed aggressive fibrosarcomas, likely triggered by Cre activation of mutant PDGFRα in fibroblastic cell lineages. Importantly, in the brain tumors and cell lines derived from brain tumor tissues, we identified a high prevalence of DM Pdgfra gene amplification, suggesting its occurrence as an early mutational event contributing to the malignant transformation of OPCs. Amplicons extended beyond the Pdgfra locus and included in some cases neighboring genes Kit and Kdr. Our genetically defined mouse brain tumor model therefore supports OPC as a cell of origin for malignant glioma and offers an example of a defined temporal sequence of mutational events, thus providing an entry point for a mechanistic understanding of DM gene amplification and its functionality in gliomagenesis.
Insights
Researchers created a mouse model for malignant glioma, revealing double minutes (DM) gene amplification of PDGF receptor alpha (PDGFRα) in oligodendrocyte precursor cells (OPCs) as an early event in brain tumor development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Oncogene amplification on extrachromosomal DNA as double minutes (DM) is common in primary brain tumors, but mechanisms are unclear.
- Oligodendrocyte precursor cells (OPCs) are implicated in glioma development.
Purpose of the Study:
- To generate a genetically defined mouse model for studying malignant glioma and double minutes (DM) gene amplification.
- To investigate the role of PDGF receptor alpha (PDGFRα) signaling in gliomagenesis.
Main Methods:
- Generated a knock-in mouse model with mutant PDGFRα in OPCs within an INK4/Arf(-/-) background.
- Analyzed brain tumors and derived cell lines for gene amplification, including DM formation.
- Characterized the cell of origin and the sequence of mutational events.
Main Results:
- The mouse model frequently developed anaplastic gliomas (WHO grade III) and fibrosarcomas.
- High prevalence of DM Pdgfra gene amplification was observed in brain tumors and cell lines.
- Amplicons extended to neighboring genes Kit and Kdr in some cases.
Conclusions:
- Oligodendrocyte precursor cells (OPCs) are a likely cell of origin for malignant gliomas.
- PDGF receptor alpha (PDGFRα) gene amplification via double minutes (DM) is an early event in gliomagenesis.
- This model provides insights into the mechanisms and functionality of DM gene amplification in brain tumor development.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020